ACRUX LIMITED - News & Media

10.0%

1.8¢

Market Cap $7.366M

Healthcare Drug Manufacturers - Specialty & Generic

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist, Dapsone Gel, 5% and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto (estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.8¢		Change -0.002(10.0%)		Mkt cap ! $7.366M

Open	High	Low	Value	Volume
1.8¢	1.8¢	1.8¢	$8.471K	470.6K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	1.8¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	370600	1

View Market Depth

No.	Vol.	Price($)
4	691823	0.017
10	960173	0.016
5	1311882	0.015
2	140000	0.014
3	486850	0.013

Price($)	Vol.	No.
0.020	370600	1
0.021	111922	1
0.022	100000	1
0.023	381179	1
0.024	201073	3

Last trade - 13.32pm 25/07/2025 (20 minute delay)

ACR (ASX) Chart

ACRUX LIMITED - News & Media

Articles & Videos

Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation

US FDA approves review of Acrux (ASX:ACR) nitroglycerin ointment

Acrux (ASX:ACR) announces buyout of future Lenzetto royalties

Buyers (Bids)

Sellers (Offers)

Top Stories